DE60010456D1 - PHARMACEUTICAL OR DIETETARY COMPOSITION FOR PREVENTING OR TREATING HYPEROXALURIA - Google Patents

PHARMACEUTICAL OR DIETETARY COMPOSITION FOR PREVENTING OR TREATING HYPEROXALURIA

Info

Publication number
DE60010456D1
DE60010456D1 DE60010456T DE60010456T DE60010456D1 DE 60010456 D1 DE60010456 D1 DE 60010456D1 DE 60010456 T DE60010456 T DE 60010456T DE 60010456 T DE60010456 T DE 60010456T DE 60010456 D1 DE60010456 D1 DE 60010456D1
Authority
DE
Germany
Prior art keywords
dietetary
pharmaceutical
preventing
composition
hyperoxaluria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60010456T
Other languages
German (de)
Other versions
DE60010456T2 (en
Inventor
Simone Claudio De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actial Farmaceutica Ltda
Original Assignee
Actial Farmaceutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actial Farmaceutica Ltda filed Critical Actial Farmaceutica Ltda
Publication of DE60010456D1 publication Critical patent/DE60010456D1/en
Application granted granted Critical
Publication of DE60010456T2 publication Critical patent/DE60010456T2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/04Drugs for disorders of the urinary system for urolithiasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
DE60010456T 1999-05-28 2000-05-24 PHARMACEUTICAL OR DIETARY COMPOSITION FOR THE PREVENTION OR TREATMENT OF HYPEROXALURIA Expired - Lifetime DE60010456T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999RM000338A IT1309427B1 (en) 1999-05-28 1999-05-28 DIETARY OR PHARMACEUTICAL COMPOSITION USEFUL FOR THE PREVENTION OR TREATMENT OF HYPEROXIDE AND ITS USE
ITRM990338 1999-05-28
PCT/IT2000/000213 WO2000072855A2 (en) 1999-05-28 2000-05-24 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria

Publications (2)

Publication Number Publication Date
DE60010456D1 true DE60010456D1 (en) 2004-06-09
DE60010456T2 DE60010456T2 (en) 2005-05-12

Family

ID=11406789

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60010456T Expired - Lifetime DE60010456T2 (en) 1999-05-28 2000-05-24 PHARMACEUTICAL OR DIETARY COMPOSITION FOR THE PREVENTION OR TREATMENT OF HYPEROXALURIA

Country Status (34)

Country Link
US (2) US6562336B2 (en)
EP (1) EP1181027B1 (en)
JP (1) JP4737836B2 (en)
KR (1) KR100781703B1 (en)
CN (1) CN100350919C (en)
AR (1) AR024555A1 (en)
AT (1) ATE265857T1 (en)
AU (1) AU773459B2 (en)
BR (1) BR0011038B1 (en)
CA (1) CA2373255C (en)
CZ (1) CZ20014076A3 (en)
DE (1) DE60010456T2 (en)
DK (1) DK1181027T3 (en)
DZ (1) DZ3165A1 (en)
EA (1) EA004257B1 (en)
EE (1) EE200100618A (en)
ES (1) ES2219344T3 (en)
HK (1) HK1048066B (en)
HU (1) HU225134B1 (en)
IL (3) IL146703A0 (en)
IS (1) IS6150A (en)
IT (1) IT1309427B1 (en)
MA (1) MA26790A1 (en)
MX (1) MXPA01012184A (en)
NO (1) NO20015782L (en)
NZ (1) NZ516020A (en)
PL (1) PL352014A1 (en)
PT (1) PT1181027E (en)
SI (1) SI1181027T1 (en)
SK (1) SK16612001A3 (en)
TR (1) TR200103439T2 (en)
UA (1) UA71621C2 (en)
WO (1) WO2000072855A2 (en)
ZA (1) ZA200110504B (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283225B1 (en) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere STRAINS OF BACTERIA, PHARMACEUTICAL COMPOSITION CONTAINING ONE OR MORE OF SUCH STRAINS AND USE OF THE SAME FOR THE PREVENTION AND THERAPY OF
US8486389B2 (en) * 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US8697051B2 (en) * 1999-06-09 2014-04-15 Vsl Pharmaceuticals Inc. Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
ITRM20010763A1 (en) * 2001-12-21 2003-06-21 Simone Claudio De NEW LACTIC BACTERIA STOCK AND EDIBLE COMPOSITIONS, DRUGS AND VETERINARY PRODUCTS THAT CONTAIN IT.
US9655932B2 (en) 2002-03-13 2017-05-23 Kibow Biotech, Inc. Composition and method for preventing or treating gout or hyperuricemia
US11103542B2 (en) 2002-03-13 2021-08-31 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
US20050074442A1 (en) * 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
AU2004249060A1 (en) * 2003-06-24 2004-12-29 Otsuka Pharmaceutical Co., Ltd. Composition for lowering serum uric acid level
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
AU2005224162A1 (en) 2004-03-19 2005-09-29 Danisco A/S Emulsifier composition for shortening
EP1814995A2 (en) * 2004-10-27 2007-08-08 North Carolina State University Lactobacillus acidophilus nucleic acids and uses thereof
AR052472A1 (en) 2005-05-31 2007-03-21 Iams Company PROBIOTIC LACTOBACILOS FOR FELINOS
AR053805A1 (en) 2005-05-31 2007-05-23 Iams Company PROBIOTIC BIFIDOBACTERIES FOR FELINOS
EP1962873B1 (en) 2005-12-14 2013-05-29 OxThera, Inc., Pharmaceutical compositions comprising oxalate-reducing bacteria
CA2633238A1 (en) 2005-12-16 2007-07-05 Oxthera, Inc. Compositions and methods for oxalate reduction
AU2008230747A1 (en) * 2007-03-27 2008-10-02 The Procter & Gamble Company Methods and kits for administering probiotics
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CN101606952B (en) * 2008-06-17 2012-09-19 上海交通大学医学院附属第三人民医院 Application of bifidobacterium lactis in preventing medicine for urinary system calculus
JP5632289B2 (en) 2008-09-30 2014-11-26 株式会社明治 Lactic acid bacteria with high oxalic acid resolution
CN101554237B (en) * 2009-03-16 2013-11-06 武汉康复得生物科技有限公司 Preparation method of oxalate-degrading enzyme contained in plant fiber or microorganism indissolvable component
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
IT1403661B1 (en) 2011-01-28 2013-10-31 Probiotical Spa EFFERVESCENT COMPOSITION IN THE SOLID FORM FOR USE IN VAGINAL APPLICATIONS FOR THE TREATMENT OF VAGINAL INFECTIONS.
ITMI20110793A1 (en) 2011-05-09 2012-11-10 Probiotical Spa STRAINS OF PROBIOTIC BACTERIA AND SYNBIOTIC COMPOSITION CONTAINING THEMSELVES INTENDED FOR THE BABY FOOD.
ITMI20110792A1 (en) 2011-05-09 2012-11-10 Probiotical Spa STRAINS OF BACTERIA BELONGING TO THE BIFIDOBACTERIUM TYPE FOR USE IN THE TREATMENT OF HYPERCOLESTEROLEMIA.
ITMI20110791A1 (en) 2011-05-09 2012-11-10 Probiotical Spa BACTERIA OF BACTERIA ABLE TO METABOLIZE THE OXALATES.
ITRM20110477A1 (en) 2011-09-09 2013-03-10 Giovanni Mogna COMPOSITION INCLUDING N-ACETYLCISTEIN AND / OR LYSOZYME MICROINCAPSULATE GASTROPROTECT IN ASSOCIATION WITH PROBIOTIC BACTERES ABLE TO RESTORE THE BARRIER EFFECT OF THE STOMACH THAT IS LOST DURING THE PHARMACOLOGICAL TREATMENT OF
ITMI20111718A1 (en) 2011-09-23 2013-03-24 Probiotical Spa A WATERPROOF MOISTURE AND OXYGEN MATERIAL FOR PACKAGING DIETARY, COSMETIC AND MEDICINAL PRODUCTS.
ITMI20121173A1 (en) * 2012-07-04 2014-01-05 Neupharma Srl DIETARY AND PHARMACEUTICAL COMPOSITIONS INCLUDING LACTOBACILLUS AND BIFIDOBACTERIUM STRIPS ABLE TO DEGRATE OXALATES AND TO INDUCE AN ANTI-INFLAMMATORY IMMUNITY RESPONSE
ITMI20130793A1 (en) 2013-05-14 2014-11-15 Probiotical Spa COMPOSITION INCLUDING LACTIC BACTERIA FOR USE IN THE PREVENTIVE AND / OR CURATIVE TREATMENT OF THE RECURRENT CYCLES.
ITMI20130795A1 (en) * 2013-05-14 2014-11-15 Probiotical Spa COMPOSITION INCLUDING LACTIC BACTERIA AND / OR BIFIDOBACTERIES FOR USE IN THE PREVENTIVE AND / OR CURATIVE TREATMENT OF BACTERIAL INFECTIONS AND / OR INFLAMMATIONS OF THE URINARY AND / OR PROSTATE TRACT THAT ARE THE CAUSE OF PROSTATITIS AND PROSTAT HYPERTROPHY
JP5765832B2 (en) * 2013-12-26 2015-08-19 雪印メグミルク株式会社 Preventive, ameliorating, and therapeutic agents for metabolic disorders associated with aging
CA2963213C (en) * 2014-10-01 2021-02-09 Triphase Pharmaceuticals Pvt. Ltd. Thermo-stable lactobacillus strains, products and methods thereof
ITUB20155752A1 (en) 2015-11-19 2017-05-19 Probiotical Spa Composition of bacteria for use to mitigate performance decreases after an exercise that damages the muscles.
CN107868776A (en) 2016-09-23 2018-04-03 武汉康复得生物科技股份有限公司 Glycosylate oxalate decarboxylase and its preparation and application
WO2018125735A1 (en) 2016-12-29 2018-07-05 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
JP2022512380A (en) * 2018-12-10 2022-02-03 ノヴォム バイオテクノロジーズ,インコーポレイテッド Methods and Compositions for Treating Hyperoxaluria
CN113308416B (en) * 2021-07-20 2023-02-24 四川大学 Lactobacillus plantarum capable of inhibiting kidney stone formation and application thereof
CN115851508B (en) * 2022-10-13 2024-01-09 山东中科嘉亿生物工程有限公司 Streptococcus thermophilus JYST-26 for reducing oxalic acid and improving kidney stones, and product and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5810520A (en) * 1981-07-10 1983-01-21 Miyarisan Kk Remedy for hepatolithiasis
DK0577904T3 (en) * 1992-07-06 1997-10-27 Nestle Sa The lactic acid bacteria.
IT1283225B1 (en) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere STRAINS OF BACTERIA, PHARMACEUTICAL COMPOSITION CONTAINING ONE OR MORE OF SUCH STRAINS AND USE OF THE SAME FOR THE PREVENTION AND THERAPY OF
DE69600525T2 (en) * 1996-12-23 1998-12-10 Sitia Yomo Spa Lyophilized food composition containing live bakery
KR20010012845A (en) * 1997-05-23 2001-02-26 아익션 바이오테크놀로지, 인코퍼레이티드 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate-related disease
RU2139346C1 (en) * 1999-03-02 1999-10-10 Шендеров Борис Аркадьевич Strain of bacterium lactobacillus plantarum showing capability to decrease oxalate level and used for preparing preparations and foodstuffs for prophylaxis and treatment of patients with hyperoxaluria

Also Published As

Publication number Publication date
BR0011038B1 (en) 2014-02-18
US6562336B2 (en) 2003-05-13
CN100350919C (en) 2007-11-28
SI1181027T1 (en) 2004-08-31
EA200101262A1 (en) 2002-04-25
AU5101600A (en) 2000-12-18
PT1181027E (en) 2004-09-30
MA26790A1 (en) 2004-12-20
HK1048066A1 (en) 2003-03-21
AR024555A1 (en) 2002-10-16
BR0011038A (en) 2002-02-26
NO20015782L (en) 2002-01-25
IL199437A0 (en) 2011-07-31
AU773459B2 (en) 2004-05-27
IT1309427B1 (en) 2002-01-23
IL146703A (en) 2010-03-28
CA2373255A1 (en) 2000-12-07
HU225134B1 (en) 2006-06-28
US20020061292A1 (en) 2002-05-23
DZ3165A1 (en) 2000-12-07
EP1181027B1 (en) 2004-05-06
HUP0201409A3 (en) 2004-10-28
KR100781703B1 (en) 2007-12-03
EP1181027A2 (en) 2002-02-27
IS6150A (en) 2001-11-08
WO2000072855A2 (en) 2000-12-07
UA71621C2 (en) 2004-12-15
ES2219344T3 (en) 2004-12-01
HUP0201409A2 (en) 2002-08-28
NZ516020A (en) 2003-06-30
CZ20014076A3 (en) 2002-03-13
IL146703A0 (en) 2002-07-25
DK1181027T3 (en) 2004-08-16
USRE39585E1 (en) 2007-04-24
TR200103439T2 (en) 2002-06-21
SK16612001A3 (en) 2002-04-04
KR20020019918A (en) 2002-03-13
MXPA01012184A (en) 2003-06-30
JP2003500451A (en) 2003-01-07
CA2373255C (en) 2010-01-19
ITRM990338A0 (en) 1999-05-28
NO20015782D0 (en) 2001-11-27
ATE265857T1 (en) 2004-05-15
DE60010456T2 (en) 2005-05-12
PL352014A1 (en) 2003-07-14
HK1048066B (en) 2008-08-01
ITRM990338A1 (en) 2000-11-28
IL199437A (en) 2016-10-31
WO2000072855A3 (en) 2001-06-28
EE200100618A (en) 2003-02-17
ZA200110504B (en) 2002-09-25
EA004257B1 (en) 2004-02-26
CN1365284A (en) 2002-08-21
JP4737836B2 (en) 2011-08-03

Similar Documents

Publication Publication Date Title
DE60010456D1 (en) PHARMACEUTICAL OR DIETETARY COMPOSITION FOR PREVENTING OR TREATING HYPEROXALURIA
ATE318138T1 (en) PHARMACEUTICAL AGENT FOR TREATING DIABETES
DE69710095T2 (en) PHARMACEUTICAL PREPARATION FOR TREATING DIABETES
DE60011570D1 (en) ARYLPIPERAZINYL-CYCLOHEXYL INDOLDER DERIVATIVES FOR TREATING DEPRESSIONS
ATE279190T1 (en) SYNERGISTIC COMPOSITIONS FOR CANCER TREATMENT
ATE204754T1 (en) PHARMACEUTICAL COMPOSITION OF METFORMIN AND FIBRATE AND USE THEREOF FOR THE TREATMENT OF HYPERGLYCEMIA
IS6304A (en) Quinazoline compounds and pharmaceutical compositions containing them
EE04464B1 (en) Indalyl-substituted benzenecarboxamides, process for their preparation, use and pharmaceutical compositions
DE10082139T1 (en) Composition for the treatment of friction pairs
EE200100391A (en) Peptidyl-heterocyclic ketones, their use and pharmaceutical composition
DE60019555D1 (en) 2-OXY-BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF FATIBILITY
DE60012138D1 (en) FIBRILLATION TREATMENT DEVICE
DK1250152T3 (en) Synergistic composition containing hyaluronic acid for the treatment of cancer
DE69941821D1 (en) FLUORENT HARDENING COMPOSITION FOR TREATING SURFACES
DE69838785D1 (en) PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CEREBRAL AMYLOIDOSIS
DE69420229D1 (en) Pharmaceutical composition for the treatment of AIDS
DE69925578D1 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING DISEASES RELATED TO EYE-BASED CELL-DISEASES
BR9806083A (en) Pharmaceutical composition for the treatment of hapattite c
DE60001255D1 (en) Composition for the treatment of polyester fiber
DE60121047D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PHIMOSIVE WITH A TOPICAL CORTICOSTEROID
PT1227817E (en) AQUOSA PHARMACEUTICAL COMPOSITION CYCLOSONIDE CONTAINING
DE10081194D2 (en) Dosage form for application in body openings
IT1299566B1 (en) TRANSDERMAL PATCH AND PHARMACEUTICAL COMPOSITIONS INCLUDING R (-) - NORAPROPYLAPOMORPHINE HYDROCHLORIDE AND / OR S (+) - NORAPROPYLAPOMORPHINE
DE69906701D1 (en) TOPICAL USE OF LOPERAMIDE FOR TREATING MICROBIAL INFECTIONS
DE59911556D1 (en) MEDICAMENT FOR AVOIDING OR TREATING PAPILLOMA-SPECIUS TUMOR

Legal Events

Date Code Title Description
8364 No opposition during term of opposition